Abstract: This invention is directed to compositions, methods and kits that can be used for the treatment or amelioration of pain and fever.

Abstract: This invention is directed to compositions, methods and kits that can be used for the treatment or amelioration of pain.

Abstract: This invention is directed to compositions, methods and kits that can be used for the treatment or amelioration of pain and fever.

Abstract: This invention is directed to compositions, methods and kits that can be used for the treatment or amelioration of pain and fever.

Abstract: Provided are compositions that include a platelet-activating factor antagonist, pharmaceutical compositions including the platelet-activating factor antagonist, methods of treating a modulating the proliferation of a glioma or a pathological condition resulting from patient having a glioma.

Abstract: This invention is directed to compositions, methods and kits that can be used for the treatment or amelioration of pain and fever.

Abstract: A metadata generation system utilizes machine learning techniques to accurately describe content of videos based on multi-model predictions. In some embodiments, multiple feature sets are extracted from a video, including feature sets showing correlations between additional features of the video. The feature sets are provided to a learnable pooling layer with multiple modeling techniques, which generates, for each of the feature sets, a multi-model content prediction. In some cases, the multi-model predictions are consolidated into a combined prediction. Keywords describing the content of the video are determined based on the multi-model predictions (or combined prediction). An augmented video is generated with metadata that is based on the keywords.

Abstract: This invention is directed to compositions, methods and kits that can be used for the treatment or amelioration of pain.

Abstract: A metadata generation system utilizes machine learning techniques to accurately describe content of videos based on multi-model predictions. In some embodiments, multiple feature sets are extracted from a video, including feature sets showing correlations between additional features of the video. The feature sets are provided to a learnable pooling layer with multiple modeling techniques, which generates, for each of the feature sets, a multi-model content prediction. In some cases, the multi-model predictions are consolidated into a combined prediction. Keywords describing the content of the video are determined based on the multi-model predictions (or combined prediction). An augmented video is generated with metadata that is based on the keywords.

Abstract: The chemically synthesized compound Tricin 7-O-beta-D-glucopyranoside, native to the plant Deschampsia Antarctica and present in aqueous extracts of the plant Deschampsia Antarctica said compound having the ability to inhibit tumor growth in mammals with colorectal carcinoma.

Abstract: Provided are compositions that include a platelet-activating factor antagonist, pharmaceutical compositions including the platelet-activating factor antagonist, methods of treating a modulating the proliferation of a glioma or a pathological condition resulting from patient having a glioma.

Abstract: The chemically synthesized compound Tricin 7-O-beta-D-glucopyranoside, native to the plant Deschampsia Antarctica and present in aqueous extracts of the plant Deschampsia Antarctica said compound having the ability to inhibit tumor growth in mammals with colorectal carcinoma.

Abstract: Novel pyroglutamic acid derivatives (I), wherein R1 is —OH, —ORa, wherein Ra is alkyl, cycloalkyl, alkenyl, cycloalkenyl, aryl, aralkyl or heterocyclyl; R2, R3 and R4 are independently H, a nitrogen protecting group which hydrolyzes under acidic conditions or phtalamide; X is a pharmaceutically acceptable anion; and Y is a N-containing group; either in the form of their isolated optically active stereoisomers or in the form of mixtures thereof, are useful compounds for enhancing an immuneresponse in a subject and/or for treating tumors, bacterial, fungal or viral infections, or autoimmune diseases.

Abstract: A location-based service includes detecting the relative motion of an on-site resource, detecting the absolute position of the on-site resource, and tracking the position of the on-site resource. The position is tracked by deriving a deduced position based on the detected relative motion and adjusting the deduced position as a function of and in response to the detected absolute position. According to one embodiment, the on-site resource can be a shopping cart and the tracking includes recording a travel pattern of the shopping cart as it moves through a site floor plan such that the travel pattern is reproducible. Preferably, the recorded travel pattern includes travel patterns within an aisle in the site floor plan such that the recorded patterns include travel along the length of the aisle and travel having components which are perpendicular to the length of the aisle.

Abstract: Novel pyroglutamic acid derivatives (I), wherein R1 is —OH, —ORa, wherein Ra is alkyl, cycloalkyl, alkenyl, cycloalkenyl, aryl, aralkyl or heterocyclyl; R2, R3 and R4 are independently H, a nitrogen protecting group which hydrolyzes under acidic conditions or phtalamide; X is a pharmaceutically acceptable anion; and Y is a N-containing group; either in the form of their isolated optically active stereoisomers or in the form of mixtures thereof, are useful compounds for enhancing an immuneresponse in a subject and/or for treating tumors, bacterial, fungal or viral infections, or autoimmune diseases.

Abstract: New 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives having the chemical structure of general formula (I), and pharmaceutically acceptable salts thereof are disclosed, as well as processes for their preparation and to pharmaceutical compositions containing them and their use in the treatment, prevention or suppression of pathological conditions, diseases and disorders susceptible of being improved by inhibition of PDE7.

Abstract: Novel pyroglutamic acid derivatives (I), wherein R1 is —OH, —ORa, wherein Ra is alkyl, cycloalkyl, alkenyl, cycloalkenyl, aryl, aralkyl or heterocyclyl; R2, R3 and R4 are independently H, a nitrogen protecting group which hydrolyzes under acidic conditions or phtalamide; X is a pharmaceutically acceptable anion; and Y is a N-containing group; either in the form of their isolated optically active stereoisomers or in the form of mixtures thereof, are useful compounds for enhancing an immuneresponse in a subject and/or for treating tumours, bacterial, fungal or viral infections, or autoimmune diseases.

Abstract: The present invention is a chemical composition including: Use of the compound with the chemical formula can be applied in pharmaceutical compositions for the treatment of psoriasis.

Abstract: The present invention is related with the field of therapeutic vaccines against pathogens causing chronic diseases. It comprises the use in therapy of formulations containing the Hepatitis B surface antigen (HBsAg) as the main compound. The HBsAg is produced as a recombinant product in Picchia pastoris. The formulations of the present invention also comprise the combination of the Hepatitis B surface antigen and other coadministered antigens. The resulting formulations are able to generate potent lymphoprolipherative and cytotoxic responses apart from a remarkable response of specific antibodies, which make them very effective in the treatment of such diseases.

Abstract: Novel pyroglutamic acid derivatives (I), wherein R1 is ?OH, ?ORa, wherein Ra is alkyl, cycloalkyl, alkenyl, cycloalkenyl, aryl, aralkyl or heterocyclyl; R2, R3 and R4 are independently H, a nitrogen protecting group which hydrolyzes under acidic conditions or phtalamide; X is a pharmaceutically acceptable anion; and Y is a N-containing group; either in the form of their isolated optically active stereoisomers or in the form of mixtures thereof, are useful compounds for enhancing an immuneresponse in a subject and/or for treating tumours, bacterial, fungal or viral infections, or autoimmune diseases.